PW Medtech Group (FRA:PWE) Cash And Cash Equivalents : €204.16 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group Cash And Cash Equivalents?

PW Medtech Group's quarterly cash and cash equivalents declined from Dec. 2022 (€187.12 Mil) to Jun. 2023 (€183.01 Mil) but then increased from Jun. 2023 (€183.01 Mil) to Dec. 2023 (€204.16 Mil).

PW Medtech Group's annual cash and cash equivalents declined from Dec. 2021 (€317.46 Mil) to Dec. 2022 (€187.12 Mil) but then increased from Dec. 2022 (€187.12 Mil) to Dec. 2023 (€204.16 Mil).

PW Medtech Group Cash And Cash Equivalents Historical Data

The historical data trend for PW Medtech Group's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group Cash And Cash Equivalents Chart

PW Medtech Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

17.02

213.92

317.46

187.12

204.16

PW Medtech Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial															317.46	204.38	187.12	183.01	204.16

PW Medtech Group Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

PW Medtech Group (FRA:PWE) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

PW Medtech Group Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

PW Medtech Group (FRA:PWE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (FRA:PWE) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

01358:Hong Kong

Address

Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204

Website

https://www.pwmedtech.com

PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.

PW Medtech Group (FRA:PWE) Headlines

No Headlines